Lipids Management: Perspective

 
 

  • Beyond BMI: Weight Loss Produces More Health Benefits   Dr Sarah Barenbaum discusses realistic weight-loss goals.
  • Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  • ACC 2025 Keep Fighting INOCA After Neutral WARRIOR Trial   Drs O’Donoghue, Handberg, and Bairey-Merz discuss the WARRIOR trial of intensive medical therapy in women with nonobstructive symptomatic CAD, presented at the ACC 2025 Scientific Session.
  • Early Statin Use Shows Sustained Cardiovascular Benefits Early introduction of atorvastatin in patients with hypertension demonstrates sustained cardiovascular benefits, a 20-year follow-up study reveals.
  • When Should You Consider Weight-Loss Meds for Obesity?   Dr Sarah Barenbaum discusses when to consider antiobesity medications.
  • Psych Patient on the Medical Unit? Focus on This   The Curbsiders discuss why you shouldn’t get bogged down with the patient’s psychiatric illness, and what to focus on instead.
  • ACC 2025 Read clinically focused news coverage of key developments from ACC 2025
  • ACC 2025 Mandrola’s 5 Picks for ACC 25 Trials on cerebral protection in TAVR, fluid restriction in heart failure, and risk factor management in AF are among John Mandrola’s picks from the upcoming ACC Scientific Sessions.
  • Cancer Survivors Show Unique CVD Patterns Cancer survivors have an elevated risk for cardiovascular diseases, with variations by cancer type and ethnicity.
  • Mar 21 2025 This Week in Cardiology   A large trial in cardiac pacing finally published, PVCs and cardiomyopathy, cannabis, CV risk and the danger of observational studies, and the tale of two disparate statin trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Statins Work — Don't Let Anyone Tell You Otherwise   In this installment of On Second Thought, Dr Christopher Labos addresses statin naysayers and cholesterol denialism.
  • Is the 30/30/30 Diet Worth Following? A new trending diet suggests that people should eat 30 grams of protein within 30 minutes of waking followed by 30 minutes of exercise. Does it live up to its hype?
  • Why Is This Patient’s Diabetes Getting Worse? An adult with suspected type 2 diabetes starts treatment with semaglutide, but his A1c keeps getting worse.
  • Berberine Ursodeoxycholate Reduces A1c in Type 2 Diabetes Berberine ursodeoxycholate, a novel gut-liver metabolic modulator, reduces A1c levels and improves glycemic, cardiometabolic, and hepatic parameters in patients with T2D over 12 weeks.
  • A New Tool Optimises Type 2 Diabetes Drug Selection A UK-based study develops and validates a five–drug class model that uses routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes.
  • Cardiac Testing? The History Wins Again   When should you order further cardiac evaluation for the hospitalized patient?
  • Should We Be Concerned About These BP Medicines? Assess risk factors and advise patients before prescribing thiazides and ACE inhibitors for blood pressure management.
  • S3 Episode 1: MASLD and Type 2 Diabetes: Screening and Management   Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction-associated steatotic liver disease in endocrine practice.
  • Gender Disparities Emerge in Spanish Cellulitis Care Factors associated with cellulitis and related hospitalisations differ by sex; however, older age and comorbidities increase the mortality rate in both sexes.
  • Feb 21 2025 This Week in Cardiology   Blanking period after AF ablation, periprocedural MI after PCI in non-STEMI, predicting AF after ischemic stroke, and the proper standards for mitral valve repair in primary mitral regurgitation are the topics John Mandrola, MD, discusses in today’s podcast.